Bimagrumab

Bimagrumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting ACVR2A/ACVR2B, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications.

Bimagrumab has been used in trials studying the treatment and supportive care of Sarcopenia, Skeletal Muscle, Mechanical Ventilation, Sporadic Inclusion Body Myositis, and Sporadic Inclusion Body Myositis (sIBM), among others.

Target	ACVR2A/ACVR2B
Clonality	Monoclonal
Reactivity	Human
Expression	Recombinant
Tested Applications	ELISA, WB
Host	Human
Recommended dilutions	Optimal dilutions/concentrations should be determined by the end user.
Conjugation	Unconjugated
Isotype	IgG1 Lambda
Form	Liquid
Purity	> 95%
Purification	Purified from cell culture supernatants by Protein A/G chromatography.
Storage	Store at 4°C if the entire vial will be used within 1-2 weeks. Aliquot and store between -20°C and -80°C. Avoid repeated freeze/thaw cycles.
Buffer	PBS pH 7.4.
CAS Number	1356922-05-8
Concentration	1.99 mg/ml
Availability	Shipped within 7-12 working days.
Note	This product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use.

Research Articles on ACVR2A/ACVR2B

Write a review

Your Name

Your Email Address

PMID

DOI

Your Review

Rating

Continue